Seemingly undeterred by months of threats from President Donald Trump, Federal Reserve Chair Jerome Powell on Wednesday ...

ImmunityBio, Inc. remains a Buy, with Anktiva’s regulatory and global expansion driving the investment thesis. Learn more ...

Stocks rose for a second straight day. Plus, Jerome Powell is set for his penultimate meeting as Fed chair.

Pakistan suffered a devastating flood season last year, prompting massive state compensation. While the compassion behind this response is unquestionable, the way relief is structured may ...

The outlook for the Australian Dollar (AUD) remains constructive for the time being, reinforced by persistently elevated ...

Arizona voters may be asked in November to decide whether to amend the state Constitution to establish the right for ...

The emotional outbursts of MAGA men can seem spontaneous and even silly – but we should take them seriously, especially when ...

The true risk of any asset class should be assessed independently of its wrapper. Credit, for instance, should be evaluated ...

Founded March 27, 2002 by Binu Mathew, we've been bringing you independent news and analysis for over two decades.

Inside how the relentless optimism of Paul Mills has helped the Shockers turn their season around at the perfect time.

The survey conducted by AAHA and Gallant found 95% of industry professionals think stem cell therapy will become a new spectrum of care standard treatment option within 10 years. The American Animal ...